3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hodgkin Disease
50
Lymphoma
45
Testicular Neoplasms
13
Teratoma
12
HIV Infections
12
Acquired Immunodeficiency Syndrome
11
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, Non-Hodgkin
9
Head and Neck Neoplasms
8
Endodermal Sinus Tumor
8
Testicular Germ Cell Tumor
7
Sarcoma, Kaposi
7
Neoplasms
7
Carcinoma, Embryonal
7
Seminoma
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Follicular
6
Ovarian Neoplasms
5
Ovarian Germ Cell Cancer
5
Recurrence
4
Neoplasms, Germ Cell and Embryonal
4
Neoplasm Metastasis
4
Carcinoma, Squamous Cell
4
Vulvar Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Teratoma, Testicular
2
Skin Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Drug-Related Side Effects and Adverse Reactions
2
Dendritic Cell Sarcoma, Interdigitating
2
Interventions
Fluorouracil
267
Oxaliplatin
266
Capecitabine
224
Leucovorin
209
Irinotecan
151
Radiotherapy
131
Bevacizumab
112
Cetuximab
81
Folfox protocol
48
Surgical Procedures, Operative
44
Radiation
41
Drug Therapy
41
Neoadjuvant Therapy
40
Chemoradiotherapy
33
Chemotherapy, Adjuvant
32
Panitumumab
27
XELOX
25
Magnetic Resonance Spectroscopy
22
Radiotherapy, Intensity-Modulated
21
Floxuridine
17
Biopsy
16
Nivolumab
15
Gemcitabine
15
Early Intervention, Educational
15
pembrolizumab
14
Laparoscopy
14
IFL protocol
14
Celecoxib
14
trifluridine tipiracil drug combination
13
Gene Expression Profiling
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Rectal Neoplasms
×
Bleomycin
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled